• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why XPeng Shares Traded Lower By Around 11%; Here Are 77 Biggest Movers From Yesterday

    8/24/22 5:56:36 AM ET
    $AERI
    $AKU
    $ALC
    $ALLR
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Medical Specialities
    Health Care
    Get the next $AERI alert in real time by email

    Gainers

    • Windtree Therapeutics, Inc. (NASDAQ:WINT) shares jumped 55.2% to close at $0.70 on Tuesday after the company announced it has entered into a global licensing agreement for the development and commercialization of KL4 surfactant and AEROSURF. The company may receive up to $78.9 million in milestones.
    • Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) jumped 53% to close at $1.49. Reviva Pharmaceuticals recently posted Q2 loss of $0.29 per share.
    • Neptune Wellness Solutions Inc. (NASDAQ:NEPT) climbed 53% to close at $3.06.
    • Indonesia Energy Corporation Limited (NYSE:INDO) shares gained 49.4% to close at $11.50 after gaining over 6% on Monday.
    • China Index Holdings Limited (NASDAQ:CIH) jumped 42.9% to close at $1.00 after the company received a preliminary non-binding proposal letter from Fang Holdings to acquire all outstanding shares of the company at $0.84 per share.
    • Avaya Holdings Corp. (NYSE:AVYA) jumped 38.6% to close at $1.11 after a Form 4 filing showed activity from 10% shareholder Theodore Walker Cheng-De King including purchase of company stock and exercise of put option contracts.
    • Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) shares jumped 36% to close at $15.16. Alcon AG (NYSE:ALC) agreed to acquire Aerie Pharmaceuticals for $15.25 per share, valuing Aerie at about $770 million.
    • Vivakor, Inc. (NASDAQ:VIVK) climbed 29.8% to close at $1.96.
    • Helius Medical Technologies, Inc. (NASDAQ:HSDT) jumped 29% to close at $0.71 after Roth Capital initiated coverage on the stock with a Buy rating and announced a price target of $5.
    • Nerdy, Inc. (NYSE:NRDY) gained 23.9% to close at $3.37 after a Form 4 filing showed company CEO Charles Cohn reported a purchase of 5 million shares of stock at an average price of $3.50 per share.
    • NLS Pharmaceutics AG (NASDAQ:NLSP) rose 23.2% to close at $0.6598.
    • Secoo Holding Limited (NASDAQ:SECO) gained 23% to settle at $0.3701. Secoo Holding recently entered into Share Purchase Agreements with Beijing HCYK Corporation Management Partner (HCYK) and Timing Capital Limited.
    • Yield10 Bioscience, Inc. (NASDAQ:YTEN) surged 21.5% to close at $3.39. Yield10 Bioscience recently posted a Q2 loss of $0.70 per share.
    • FGI Industries Ltd. (NASDAQ:FGI) gained 19.8% to close at $3.33. FGI Industries recently posted Q3 EPS of $0.10.
    • Eqonex Limited (NASDAQ:EQOS) jumped 19.8% to settle at $0.64 after declining around 5% on Monday.
    • FiscalNote Holdings, Inc. (NASDAQ:NOTE) gained 19.3% to close at $10.32. FiscalNote Holdings recently posted a Q2 loss of $3.06 per share.
    • Amesite Inc. (NASDAQ:AMST) climbed 18% to close at $0.7477 after the company announced it has partnered with Central Michigan University to deliver a complete Enterprise Learning Community Environment.
    • New Concept Energy, Inc. (NYSE:GBR) rose 17.2% to close at $1.98. New Concept Energy recently posted Q2 EPS of $0.02.
    • AMC Entertainment Holdings, Inc. (NYSE:APE) gained 17% to close at $7.02.
    • Akumin Inc. (NASDAQ:AKU) gained 16.4% to settle at $1.28.
    • Enservco Corporation (NASDAQ:ENSV) rose 16.1% to close at $1.95. Enservco, last month, posted Q1 sales of $4.08 million.
    • Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) gained 15.7% to settle at $1.55.
    • Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) jumped 15.4% to settle at $1.72.
    • Gravitas Education Holdings, Inc. (NASDAQ:GEHI) gained 15.4% to close at $0.60.
    • Tritium DCFC Limited (NASDAQ:DCFC) climbed 13.9% to settle at $7.31. Tritium highlighted opening of first global EV fast charger manufacturing facility in the US.
    • Houston American Energy Corp. (NYSE:HUSA) climbed 13.9% to close at $5.00.
    • Art's-Way Manufacturing Co., Inc. (NASDAQ:ARTW) gained 12.8% to close at $2.38.
    • Invacare Corporation (NYSE:IVC) gained 12.4% to close at $0.91. Invacare reported cooperation agreement with Azurite Management.
    • Verve Therapeutics, Inc. (NASDAQ:VERV) rose 12.3% to settle at $36.77. Verve Therapeutics announced new preclinical data supporting the nomination of the company's second product candidate, VERVE-201.
    • Eargo, Inc. (NASDAQ:EAR) shares gained 12.2% to close at $2.48.
    • Palo Alto Networks, Inc.(NASDAQ:PANW) climbed 12.1% to settle at $569.51 as the company reported better-than-expected results for its fourth quarter and issued FY23 guidance above estimates. The company’s board also announced a three-for-one stock split.
    • Quotient Limited (NASDAQ:QTNT) shares gained 11.7% to close at $0.2166. Quotient recently reported a wider Q1 loss.
    • Intellia Therapeutics, Inc. (NASDAQ:NTLA) jumped 11.6% to close at $60.56. Intellia Therapeutics will present interim clinical data from ongoing Phase 1/2 study of NTLA-2002 for treatment of hereditary angioedema at 2022 Bradykinin Symposium.
    • Borr Drilling Limited (NYSE:BORR) shares rose 11.5% to close at $4.06. Borr Drilling recently announced US offering 6.9 million common shares at public offering price of $3.60 per share.
    • XP Inc. (NASDAQ:XP) climbed 11% to close at $21.62.
    • PagSeguro Digital Ltd. (NYSE:PAGS) gained 10.3% to close at $14.01.
    • Waitr Holdings Inc. (NASDAQ:WTRH) rose 9.9% to close at $0.2872. Waitr Holdings said its on-demand delivery brand ASAP has entered into a partnership agreement with the online food delivery search engine, FoodBoss.
    • Relay Therapeutics, Inc. (NASDAQ:RLAY) gained 9.6% to settle at $23.01.
    • Intelligent Living Application Group Inc. (NASDAQ:ILAG) rose 9.4% to close at $3.14.
    • F45 Training Holdings Inc. (NYSE:FXLV) gained 8.8% to close at $2.34.
    • Renovacor, Inc. (NYSE:RCOR) rose 8.8% to close at $1.85. Renovacor recently reported Q2 loss of $0.23 per share.
    • Marin Software Incorporated (NASDAQ:MRIN) rose 8.6% to close at $1.90 after the company announced the ability to optimize Snapchat ad campaigns through its MarinOne platform.
    • HighPeak Energy, Inc. (NASDAQ:HPK) gained 8.1% to close at $22.75. Shares of energy companies traded higher amid a gain in oil after Saudi Arabia suggested OPEC+ could make output cuts to support prices.
    • Six Flags Entertainment Corporation (NYSE:SIX) rose 8.1% to close at $24.41.
    • Codere Online Luxembourg, S.A. (NASDAQ:CDRO) jumped 6.2% to close at $2.58.
    • SentinelOne, Inc. (NYSE:S) rose 6% to close at $27.78.

     

    Losers

    • WeTrade Group, Inc. (NASDAQ:WETG) dipped 39% to close at $3.22. The company announced it has entered into strategic partnership with Guyguide to exclusively design and provide Monkeypox testing kits and insurance coverage products for traveling packages to US, Canada, Australia and European countries.
    • Golden Sun Education Group Limited (NASDAQ:GSUN) shares fell 38.9% to close at $21.99 on Tuesday.
    • Bright Minds Biosciences Inc. (NASDAQ:DRUG) shares fell 38.4% to close at $1.33 after jumping around 73% on Monday.
    • Aspira Women's Health Inc. (NASDAQ:AWH) dipped 37.3% to settle at $0.5519. Aspira Women's Health priced 12 million share common stock offering at $0.75 per share.
    • GigaCloud Technology Inc. (NASDAQ:GCT) dropped 35.7% to close at $26.64 after declining around 14% on Monday.
    • Genius Group Limited (NYSE:GNS) dipped 30.6% to close at $3.59.
    • AnPac Bio-Medical Science Co., Ltd. (NASDAQ:ANPC) declined 29.8% to close at $0.2501 after jumping 66% on Monday.
    • Foghorn Therapeutics Inc. (NASDAQ:FHTX) fell 25.1% to close at $11.00 after the company announced the FDA has placed a clinical hold on the Phase 1 dose escalation study of FHD-286.
    • Assertio Holdings, Inc. (NASDAQ:ASRT) declined 24.7% to close at $2.74 after the company priced a $60 million convertible senior notes offering.
    • Allarity Therapeutics, Inc. (NASDAQ:ALLR) fell 23.7% to close at $1.16 after Ladenburg Thalmann downgraded the stock from Buy to Neutral.
    • Akili, Inc. (NASDAQ:AKLI) fell 20.3% to close at $5.70.
    • Sientra, Inc. (NASDAQ:SIEN) fell 19% to close at $0.66. Sientra recently posted a Q2 loss of $0.29 per share.
    • NantHealth, Inc. (NASDAQ:NH) fell 18.9% to close at $0.4240. NantHealth recently posted a Q2 loss of $0.10 per share.
    • Jowell Global Ltd. (NASDAQ:JWEL) dropped 16.5% to settle at $1.11.
    • Zoom Video Communications, Inc. (NASDAQ:ZM) fell 16.5% to close at $81.32. Zoom Video reported better-than-expected earnings for its second quarter, but sales missed expectations. The company ended the quarter with 204,100 Enterprise customers, up 18% year-over-year.
    • Innovative Eyewear, Inc. (NASDAQ:LUCY) dropped 15.6% to close at $3.6901. Innovative Eyewear recently priced its 980,000 unit IPO at $7.50 per unit.
    • Forza X1, Inc. (NASDAQ:FRZA) fell 15% to close at $4.93. Forza X1, along with OneWater Marine, recently announced the companies have entered into a strategic partnership to create a distribution channel for the Forza X1's integrated electric sports boats.
    • Healthcare Triangle, Inc. (NASDAQ:HCTI) fell 14.9% to close at $0.5105. Healthcare Triangle recently filed for resale of up 12.6 million shares of common stock by selling stockholders.
    • Wag! Group Co. (NASDAQ:PET) dropped 14.7% to close at $6.51. Wag! Recently posted Q2 revenue of $12.8 million.
    • NightHawk Biosciences, Inc. (NYSE:NHWK) declined 14.6% to close at $2.17. NightHawk Biosciences recently said it would fund development of a monkeypox vaccine.
    • DLocal Limited (NASDAQ:DLO) fell 13.9% to close at $25.51. Dlocal reported second-quarter revenue growth of 71.6% year-over-year to $101.2 million, beating the consensus of $98.53 million.
    • SaverOne 2014 Ltd (NASDAQ:SVRE) fell 13.8% to close at $2.55.
    • PLAYSTUDIOS, Inc. (NASDAQ:MYPS) fell 13.1% to settle at $3.45. B of A Securities initiated coverage on PLAYSTUDIOS with an Underperform rating and announced a price target of $3.
    • XPeng Inc. (NYSE:XPEV) dropped 10.8% to settle at $18.73 after the company reported Q2 EPS results down year over year and worse-than-expected sales results.
    • Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) fell 10.7% to close at $9.00.
    • Microvast Holdings, Inc. (NASDAQ:MVST) fell 9.2% to close at $2.5050.
    • IHS Holding Limited (NYSE:IHS) fell 8.6% to close at $7.12. IHS Holding recently reported Q2 EPS results down year-over-year.
    • AMC Entertainment Holdings, Inc. (NYSE:AMC) dropped 8.6% to close at $9.56.
    • Aspen Group, Inc. (NASDAQ:ASPU) fell 8.3% to close at $0.8528.
    • Twitter, Inc. (NYSE:TWTR) declined 7.3% to settle at $39.86 following reports suggesting an ex-Twitter executive blows the whistle on the company, alleging reckless and negligent cybersecurity policies.
    • Summit Therapeutics Inc. (NASDAQ:SMMT) declined 6.1% to close at $1.53 after surging more than 48% on Monday.
    Get the next $AERI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AERI
    $AKU
    $ALC
    $ALLR

    CompanyDatePrice TargetRatingAnalyst
    Alcon Inc.
    $ALC
    2/26/2026$97.00Equal Weight → Overweight
    Wells Fargo
    Palo Alto Networks Inc.
    $PANW
    2/18/2026$230.00 → $200.00Outperform
    BMO Capital Markets
    Foghorn Therapeutics Inc.
    $FHTX
    2/17/2026$12.00Buy
    Jefferies
    Zoom Communications Inc.
    $ZM
    2/5/2026$115.00Peer Perform → Outperform
    Wolfe Research
    Alcon Inc.
    $ALC
    1/30/2026Mkt Perform
    William Blair
    Codere Online Luxembourg S.A.
    $CDRO
    1/30/2026$8.50Buy → Hold
    Stifel
    Relay Therapeutics Inc.
    $RLAY
    1/26/2026$14.00Perform → Outperform
    Oppenheimer
    XP Inc.
    $XP
    1/20/2026$22.00Buy
    Jefferies
    More analyst ratings

    $AERI
    $AKU
    $ALC
    $ALLR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Peterson Scott Edward bought 11,593 shares, converted options into 83,334 shares, covered exercise/tax liability with 37,209 shares, disposed of 46,125 shares and acquired 34,593 shares (SEC Form 4)

    4 - PLAYSTUDIOS, Inc. (0001823878) (Issuer)

    1/20/26 6:37:01 PM ET
    $MYPS
    Computer Software: Prepackaged Software
    Technology

    Director Cohen Fred E bought $1,402,500 worth of shares (150,000 units at $9.35), increasing direct ownership by 261% to 207,453 units (SEC Form 4)

    4 - Intellia Therapeutics, Inc. (0001652130) (Issuer)

    1/7/26 4:05:06 PM ET
    $NTLA
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Director Peek Mark S bought $595,600 worth of shares (40,000 units at $14.89) (SEC Form 4)

    4 - SentinelOne, Inc. (0001583708) (Issuer)

    12/18/25 5:49:46 PM ET
    $S
    Computer Software: Prepackaged Software
    Technology

    $AERI
    $AKU
    $ALC
    $ALLR
    SEC Filings

    View All

    SEC Form 10-K filed by Zoom Communications Inc.

    10-K - Zoom Communications, Inc. (0001585521) (Filer)

    2/27/26 5:18:02 PM ET
    $ZM
    Computer Software: Programming Data Processing
    Technology

    Healthcare Triangle Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Healthcare Triangle, Inc. (0001839285) (Filer)

    2/27/26 5:00:18 PM ET
    $HCTI
    EDP Services
    Technology

    SEC Form 424B5 filed by Healthcare Triangle Inc.

    424B5 - Healthcare Triangle, Inc. (0001839285) (Filer)

    2/27/26 12:12:02 PM ET
    $HCTI
    EDP Services
    Technology

    $AERI
    $AKU
    $ALC
    $ALLR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Ying Wei was granted 67,857 shares, increasing direct ownership by 23% to 368,789 units (SEC Form 4)

    4 - Microvast Holdings, Inc. (0001760689) (Issuer)

    2/25/26 6:55:11 PM ET
    $MVST
    Industrial Machinery/Components
    Miscellaneous

    EVP, General Counsel Schlessinger Sam converted options into 1,143 shares and covered exercise/tax liability with 510 shares, increasing direct ownership by 4% to 14,738 units (SEC Form 4)

    4 - Assertio Holdings, Inc. (0001808665) (Issuer)

    2/24/26 6:02:27 PM ET
    $ASRT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    EVP and CFO Patel Ajay converted options into 1,143 shares and covered exercise/tax liability with 566 shares, increasing direct ownership by 4% to 15,942 units (SEC Form 4)

    4 - Assertio Holdings, Inc. (0001808665) (Issuer)

    2/24/26 6:01:53 PM ET
    $ASRT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AERI
    $AKU
    $ALC
    $ALLR
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for VOQUEZNA issued to PHATHOM PHARMACEUTICALS INC

    Submission status for PHATHOM PHARMACEUTICALS INC's drug VOQUEZNA (ORIG-1) with active ingredient VONOPRAZAN FUMARATE has changed to 'Approval' on 07/17/2024. Application Category: NDA, Application Number: 218710, Application Classification: Type 9 - New Indication Submitted as Distinct NDA, Consolidated with Original NDA after Approval

    7/18/24 10:52:01 AM ET
    $PHAT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for VOQUEZNA TRIPLE PAK issued to PHATHOM PHARMACEUTICALS, INC

    Submission status for PHATHOM PHARMACEUTICALS, INC's drug VOQUEZNA TRIPLE PAK (ORIG-1) with active ingredient AMOXICILLIN; CLARITHROMYCIN; VONOPRAZAN has changed to 'Approval' on 05/03/2022. Application Category: NDA, Application Number: 215152, Application Classification: Type 1 - New Molecular Entity and Type 4 - New Combination

    5/11/22 10:51:07 AM ET
    $PHAT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for VOQUEZNA DUAL PAK issued to PHATHOM PHARMACEUTICALS, INC

    Submission status for PHATHOM PHARMACEUTICALS, INC's drug VOQUEZNA DUAL PAK (ORIG-1) with active ingredient AMOXICILLIN; VONOPRAZAN has changed to 'Approval' on 05/03/2022. Application Category: NDA, Application Number: 215153, Application Classification: Type 5 - New Formulation or New Manufacturer

    5/11/22 10:17:03 AM ET
    $PHAT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AERI
    $AKU
    $ALC
    $ALLR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Alcon upgraded by Wells Fargo with a new price target

    Wells Fargo upgraded Alcon from Equal Weight to Overweight and set a new price target of $97.00

    2/26/26 7:10:22 AM ET
    $ALC
    Ophthalmic Goods
    Health Care

    BMO Capital Markets reiterated coverage on Palo Alto Networks with a new price target

    BMO Capital Markets reiterated coverage of Palo Alto Networks with a rating of Outperform and set a new price target of $200.00 from $230.00 previously

    2/18/26 6:52:21 AM ET
    $PANW
    Computer peripheral equipment
    Technology

    Jefferies resumed coverage on Foghorn Therapeutics with a new price target

    Jefferies resumed coverage of Foghorn Therapeutics with a rating of Buy and set a new price target of $12.00

    2/17/26 7:49:23 AM ET
    $FHTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AERI
    $AKU
    $ALC
    $ALLR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Healthcare Triangle Subsidiary QuantumNexis Inc. Launches its Dubai, UAE Operations to accelerate Digital Health Transformation across the GCC Countries

    The Dubai Operation strengthens Healthcare Triangle's mission to accelerate TeleHelath, Digital Therapeutics and population-scale care delivery across GCC.PLEASANTON, Calif., Feb. 27, 2026 /CNW/ -- Healthcare Triangle, Inc. (NASDAQ:HCTI) ("HCTI" or the "Company"), a leader in digital transformation solutions including managed services, cloud enablement, and data analytics for the healthcare and life sciences industries, today announced that its subsidiary QuantumNexis Inc. has launched its Dubai, UAE operations in Meydan Free Zone to deliver clinically validated digital mental health solutions and AI powered Hospital Information System to the GCC markets. "This marks a major strategic expans

    2/27/26 7:18:00 AM ET
    $HCTI
    EDP Services
    Technology

    Summit Therapeutics to Present at Upcoming Investor Conferences

    Summit Therapeutics Inc. (NASDAQ:SMMT) ("Summit," "we," or the "Company") today announced that it will participate in three upcoming investor conferences during March of this year. Members of the Summit leadership team will participate in individual investor meetings along with some fireside chats at the following conferences: TD Cowen's 46th Annual Health Care Conference in Boston on Monday, March 2, 2026 Fireside chat 2:30pm ET Jefferies Conference in Miami on Tuesday, March 10, 2026 Investor meetings only Citizens Life Sciences Conference in Miami on Wednesday, March 11, 2026 Fireside chat 2:15pm ET The fireside chats will be available live on our website: www.

    2/26/26 6:45:00 PM ET
    $SMMT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    National CineMedia, Inc. Reports Results for Fiscal Fourth Quarter and Full Year 2025

    Fourth quarter operating income increases year-over-year and fourth quarter adjusted OIBDA exceeds guidance Fourth quarter revenue growth of 8% outpaced attendance as NCM attracted greater advertiser demand National CineMedia, Inc. (NASDAQ:NCMI) (the "Company" or "NCM"), the managing member of National CineMedia, LLC (NCM LLC), the operator of the largest cinema advertising platform in the U.S., announced today its consolidated results for the fiscal fourth quarter and year ended January 1, 2026. "NCM expanded fourth quarter revenue by 8% year-over-year, demonstrating the returns from our continued investment in our platform over the course of the year," said Tom Lesinski, Chief Execu

    2/26/26 4:05:00 PM ET
    $AMC
    $CNK
    $NCMI
    Movies/Entertainment
    Consumer Discretionary
    Advertising

    $AERI
    $AKU
    $ALC
    $ALLR
    Leadership Updates

    Live Leadership Updates

    View All

    Foghorn Therapeutics Strengthens Financial Leadership with Appointment of Ryan Maynard as Chief Financial Officer

    WATERTOWN, Mass., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Foghorn® Therapeutics Inc. (NASDAQ:FHTX), a clinical-stage biotechnology company pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression, today announced that Ryan Maynard will join the company as Chief Financial Officer (CFO) on February 23, 2026. Mr. Maynard joins Foghorn with over 25 years of executive experience driving financial strategy, capital markets execution, and operational performance across public and private biopharmaceutical companies. "I am delighted to welcome Ryan to Foghorn as our new CFO as we continue to advance our first-in-class pipeline," said Adrian Gottschalk, Pres

    2/23/26 7:00:00 AM ET
    $FHTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Rigel Appoints Michael P. Miller to the Board of Directors

    SOUTH SAN FRANCISCO, Calif., Feb. 3, 2026 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) today announced that it has appointed Michael P. Miller to its Board of Directors. Mr. Miller has more than four decades of experience in commercial and leadership roles in the biotechnology and pharmaceutical industries. "Mike has a strong track record of commercial excellence, and we're delighted to have him join our Board," said Raul Rodriguez, Rigel's president and CEO. "His extensive expertise in commercial execution and leadership will provide valuable insights as we execute on our transformational strategic plan, particularly our objectives of growing our current portfolio of medicines

    2/3/26 8:05:00 AM ET
    $RIGL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Workiva Announces Two New Appointments to Board of Directors

    Company Appoints Former Cisco and Autodesk CFO Scott Herren and Former Workday Co-President, CFO, and EVP Mark Peek Workiva Inc. (NYSE:WK), a leading, AI-powered platform for trust, transparency, and accountability, today announced the appointment of two new independent directors to its Board of Directors. Scott Herren is the former EVP and Chief Financial Officer of Cisco and current Board member and Audit Committee Chair at Rubrik (NYSE:RBRK). Mark Peek is a former EVP, CFO, and Co-President of Workday (NASDAQ:WDAY) and currently sits on the Board of Directors for SentinelOne (NYSE:S) and Trimble (NASDAQ:TRMB). "We are pleased to welcome two highly experienced SaaS leaders to our Boar

    1/28/26 4:05:00 PM ET
    $RBRK
    $S
    $TRMB
    Computer Software: Prepackaged Software
    Technology
    Industrial Machinery/Components
    Industrials

    $AERI
    $AKU
    $ALC
    $ALLR
    Financials

    Live finance-specific insights

    View All

    National CineMedia, Inc. Reports Results for Fiscal Fourth Quarter and Full Year 2025

    Fourth quarter operating income increases year-over-year and fourth quarter adjusted OIBDA exceeds guidance Fourth quarter revenue growth of 8% outpaced attendance as NCM attracted greater advertiser demand National CineMedia, Inc. (NASDAQ:NCMI) (the "Company" or "NCM"), the managing member of National CineMedia, LLC (NCM LLC), the operator of the largest cinema advertising platform in the U.S., announced today its consolidated results for the fiscal fourth quarter and year ended January 1, 2026. "NCM expanded fourth quarter revenue by 8% year-over-year, demonstrating the returns from our continued investment in our platform over the course of the year," said Tom Lesinski, Chief Execu

    2/26/26 4:05:00 PM ET
    $AMC
    $CNK
    $NCMI
    Movies/Entertainment
    Consumer Discretionary
    Advertising

    Nerdy Announces Fourth Quarter 2025 Financial Results

    Nerdy returns to year-over-year revenue growth and delivers positive non-GAAP Adjusted EBITDA in Q4 2025, beating guidance on both metrics and demonstrating significant improvement in the Company's cost structure. Nerdy completes replatforming and launch of its Live+AI™ platform using AI-native coding during the fourth quarter, providing the Company with significant momentum as we enter 2026. Nerdy Inc. (NYSE:NRDY) today announced financial results for the fourth quarter and year ended December 31, 2025. "In the fourth quarter, we returned to year-over-year revenue growth and delivered positive non-GAAP adjusted EBITDA, beating the top end of our guidance range for both metrics. We dr

    2/26/26 4:01:00 PM ET
    $NRDY
    Other Consumer Services
    Real Estate

    Codere Online Reports Financial Results for the Fourth Quarter and Full Year 2025

    The Company delivered a strong set of results, with record net gaming revenueof €224.1 million and Adj. EBITDA of €13.8 million for FY 2025 Total revenue was €57.1 mm in Q4 2025, while net gaming revenue1 was €60.7 mm, 15% above Q4 2024.Mexico revenue was €29.4 mm in Q4 2025, while net gaming revenue was €32.8 mm, 31% above Q4 2024.Adj. EBITDA reached €6.7 mm in Q4 2025, €4.8 mm above Q4 2024.Net loss was €1.8 mm in 2025 versus a net income of €3.9 mm in 2024.Total cash position of €50.0 mm and no financial debt as of December 31, 2025.Outlook for FY 2026: Net gaming revenue of €235-245 mm and Adj. EBITDA2 of €15-20 mm.391 thousand repurchased shares for an aggregate amount of $2.7 mm under

    2/26/26 7:44:15 AM ET
    $CDRO
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    $AERI
    $AKU
    $ALC
    $ALLR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by SentinelOne Inc.

    SC 13D/A - SentinelOne, Inc. (0001583708) (Subject)

    12/12/24 6:30:27 PM ET
    $S
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13D/A filed by Enservco Corporation

    SC 13D/A - Enservco Corp (0000319458) (Subject)

    12/10/24 4:00:16 PM ET
    $ENSV
    Oilfield Services/Equipment
    Energy

    Amendment: SEC Form SC 13D/A filed by Nerdy Inc.

    SC 13D/A - Nerdy Inc. (0001819404) (Subject)

    12/4/24 4:01:10 PM ET
    $NRDY
    Other Consumer Services
    Real Estate

    $AERI
    $AKU
    $ALC
    $ALLR
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Insider Analysis: Purchase at Assertio Holdings Inc. on Jun 6

    Recent insider transactions at Assertio Holdings Inc. have brought attention to the company's stock activity. On June 6, 2024, Mason Heather L purchased $24,250 worth of shares, acquiring 25,000 units at $0.97 per share. This transaction increased Mason Heather L's direct ownership by 13% to 212,650 units, as reported in the SEC Form 4. Several other notable insider transactions have taken place at Assertio Holdings Inc. leading up to this purchase. Patel Ajay, Schwichtenberg Paul, and Schlessinger Sam all converted options into shares and covered exercise/tax liability by utilizing their shares. These transactions resulted in ownership increases of 16%, 20%, and 21%, respectively. Addition

    6/10/24 1:20:50 AM ET
    $ASRT
    Biotechnology: Pharmaceutical Preparations
    Health Care